Workflow
Revance(RVNC) - 2024 Q2 - Earnings Call Transcript
RVNCRevance(RVNC)2024-08-09 17:13

Revance Therapeutics, Inc. (NASDAQ:RVNC) Q2 2024 Earnings Conference Call August 8, 2024 4:30 PM ET Company Participants Laurence Watts - Investor Relations Mark Foley - Chief Executive Officer & President Tobin Schilke - Chief Financial Officer Conference Call Participants Seamus Fernandez - Guggenheim Chris Shibutani - Goldman Sachs Stacy Ku - TD Cowen David Amsellem - Piper Sandler Annabel Samimy - Stifel Lachlan Hanbury - William Blair Uy Ear - Mizuho Serge Belanger - Needham & Company Navann Ty - BNP P ...